0001104659-23-107217.txt : 20231005
0001104659-23-107217.hdr.sgml : 20231005
20231005164146
ACCESSION NUMBER: 0001104659-23-107217
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231003
FILED AS OF DATE: 20231005
DATE AS OF CHANGE: 20231005
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PFREUNDSCHUH PETER P.
CENTRAL INDEX KEY: 0001585839
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37625
FILM NUMBER: 231311853
MAIL ADDRESS:
STREET 1: C/O IMMUNOMEDICS, INC.
STREET 2: 300 THE AMERICAN ROAD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Voyager Therapeutics, Inc.
CENTRAL INDEX KEY: 0001640266
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 64 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-259-5340
MAIL ADDRESS:
STREET 1: 64 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
tm2327817-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-10-03
0
0001640266
Voyager Therapeutics, Inc.
VYGR
0001585839
PFREUNDSCHUH PETER P.
C/O VOYAGER THERAPEUTICS, INC.,
64 SIDNEY STREET
CAMBRIDGE
MA
02139
0
1
0
0
Chief Financial Officer
0
Common Stock
2023-10-03
4
S
0
13567
6.99
D
149433
D
Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on October 1, 2023. The sales do not represent a discretionary trade by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.88 to $7.24, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
/s/ Scott MacDonald, as Attorney-in-Fact for Peter P. Pfreundschuh
2023-10-05